Background illustration for clinical trials search

Paid Clinical Trials Washington State

Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

for
Parkinson Disease
Location: Boston MA, New York NY, Durham NC, Boca Raton FL,
Sponsor: Appello Pharmaceuticals, Inc.

Sex: All

Age: 30 - 70+

Code: NCT07432958

Phase2, Recruiting
Active & Responsive

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

for
Type I Diabetes
Location: Birmingham AL, Chicago IL, Aurora CO, Renton WA,
Sponsor: Op-T LLC

Sex: All

Age: 18 - 50

Code: NCT06964087

Phase2, Recruiting
Active & Responsive

FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 6

Code: NCT06609928

Phase1, Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Boston MA, North Haven CT, New York NY, Baltimore MD,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase3, Recruiting
Active & Responsive

The Airports, Air Quality, and Asthma (AAA) Study

for
Pediatric Asthma
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 6 - 12

Code: NCT07047430

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 6+

Code: NCT05416307

Phase2, Phase3, Recruiting
Active & Responsive

A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

for
Cervical Dystonia
Location: New York NY, Boca Raton FL, Farmington Hills MI,
Sponsor: Ipsen

Sex: All

Age: 18 - 70+

Code: NCT06937931

Phase2, Recruiting
Active & Responsive

Serial Blood Count Study

for
Cyclic Neutropenia, Congenital Neutropenia, Neutropenia
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 5+

Code: NCT07066085

Early_phase1, Recruiting
Active & Responsive

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

for
Metastatic Solid Tumors
Location: Nashville TN, Houston TX, Irving TX, San Antonio TX,
Sponsor: Erasca, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07021898

Phase1, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

Contour Neurovascular Systemâ„¢ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)

for
Cerebral Aneurysms
Location: Stony Brook NY, Philadelphia PA, Raleigh NC,
Sponsor: Cerus Endovascular, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06693011

Recruiting
Active & Responsive

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

for
Diabetes Mellitus Type 2
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 14 - 40

Code: NCT06936670

Recruiting
Active & Responsive

Clenbuterol to Target DUX4 in FSHD

for
Muscular Dystrophy, Facioscapulohumeral
Location: Rochester NY, Kansas City KS, Seattle WA
Sponsor: Jeffrey Statland

Sex: All

Age: 18 - 70+

Code: NCT06721299

Phase1, Recruiting
Active & Responsive

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

for
Atopic Dermatitis
Location: Fredericton, Quebec, New York NY, Montreal,
Sponsor: Apogee Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07003425

Phase2, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for
Huntington Disease
Location: Boston MA, Farmington CT, New York NY, Burlington VT,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 21 - 70

Code: NCT07326709

Phase3, Recruiting
Active & Responsive

MagDI U.S. Registry

for
Anastomosis, Surgical, Internal Hernia, Bowel Obstruction
Location: Cary NC, Miami FL, Louisville KY, Lafayette LA,
Sponsor: GT Metabolic Solutions, Inc.

Sex: All

Age: 22+

Code: NCT06928545

Recruiting
Active & Responsive

Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

for
Diabetes Mellitus, Type 2,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 40 - 65

Code: NCT05780905

Recruiting
Active & Responsive

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

for
Advanced Melanoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT05549297

Phase3, Recruiting
Active & Responsive

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

for
Ulcerative Colitis
Location: Providence RI, New York NY, Montreal, Chevy Chase MD,
Sponsor: Takeda

Sex: All

Age: 18 - 65

Code: NCT06095128

Recruiting
Active & Responsive

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: London, Halifax, Providence RI, New York NY, Montreal,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06233461

Phase2, Recruiting

Popular cities in Washington State